Photo from Nicolas Hubacz/LinkedIn
Oct 25, 2023, 17:44
Nicolas Hubacz: Top Selling Pharmaceuticals of 2023
Nicolas Hubacz shared on LinkedIn:
“Top Selling Pharmaceuticals of 2023.
As the COVID-19 pandemic’s grip lessened in 2023, the pharmaceutical industry once again relied heavily on immunology and oncology driving their sales.
An in-depth examination of financial records by Drug Discovery & Development showed that sales in immunology, oncology, and infectious diseases reached $35.23 billion, $64.41 billion, and $39.95 billion, respectively!
- Keytruda (pembrolizumab) – Merck
- Eliquis (apixaban) – Pfizer-Bristol Myers Squibb
- Ozempic (semaglutide) – Novo Nordisk
- Humira (adalimumab) – AbbVie
- Comirnaty (covid19 vaccine) – Pfizer-BioNTech SE
- Dupixent (dupilumab) by Sanofi – Regeneron
- Stelara (ustekinumab) – Janssen Inc.
- Biktarvy (bictegravir, emtricitabine, tenofovir, alafenamide) – Gilead Sciences
- Imbruvica (ibrutinib) – Janssen Inc.
- Gardasil (HPV vaccine) – Merck
Credit to Scientome.”
Source: Nicolas Hubacz/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14